Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001890280 | SCV002149673 | uncertain significance | Alpha-methylacyl-CoA racemase deficiency | 2022-09-07 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 1382430). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with AMACR-related conditions. This variant is present in population databases (rs770694101, gnomAD 0.007%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 171 of the AMACR protein (p.Arg171His). |
Ambry Genetics | RCV004641736 | SCV005129996 | uncertain significance | Inborn genetic diseases | 2024-05-01 | criteria provided, single submitter | clinical testing | The c.512G>A (p.R171H) alteration is located in exon 3 (coding exon 3) of the AMACR gene. This alteration results from a G to A substitution at nucleotide position 512, causing the arginine (R) at amino acid position 171 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |